Evidence map›Paper›PMID 36304949›Full record

ReviewFrontiers in microbiology2022

Resveratrol biosynthesis, optimization, induction, bio-transformation and bio-degradation in mycoendophytes.

M A Abo-Kadoum, Mohamed E Abouelela, Amal A Al Mousa, Nageh F Abo-Dahab, Mohamed A Mosa, Yosra A Helmy, Abdallah M A Hassane

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Frontiers in microbiology · 2024
    Article
  19. The Interactions between Two Fungal EndophytesJournal of fungi (Basel, Switzerland) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

M A Abo-KadoumDepartment of Botany and Microbiology, Faculty of Science, Al-Azhar University, Assiut, Egypt.
Mohamed E AbouelelaDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.
Amal A Al MousaDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Nageh F Abo-DahabDepartment of Botany and Microbiology, Faculty of Science, Al-Azhar University, Assiut, Egypt.
Mohamed A MosaNanotechnology and Advanced Nano-Materials Laboratory (NANML), Plant Pathology Research Institute, Agricultural Research Center, Giza, Egypt.
Yosra A HelmyDepartment of Veterinary Science, College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY, United States.
Abdallah M A HassaneDepartment of Botany and Microbiology, Faculty of Science, Al-Azhar University, Assiut, Egypt.
Al-Azhar University · EGAgricultural Research Center · EGKing Saud University · SASuez Canal University · EGUniversity of Kentucky · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (3,4,5-trihydroxystilbene) is a naturally occurring polyphenolic stilbene compound produced by certain plant species in response to biotic and abiotic factors. Resveratrol has sparked a lot of interest due to its unique structure and approved therapeutic properties for the prevention and treatment of many diseases such as neurological disease, cardiovascular disease, diabetes, inflammation, cancer, and Alzheimer's disease. Over the last few decades, many studies have focused on the production of resveratrol from various natural sources and the optimization of large-scale production. Endophytic fungi isolated from various types of grapevines and

Indexed as

bio-degradationbiosynthesisbio-transformationendophytic fungiinductionkey genesoptimizationresveratrol

Identifiers

PMID36304949
PMCPMC9593044
OpenAlexW4304182475

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.